Market cap
₹7 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
--
P/B Ratio
-6.5
Div. Yield
0 %
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
7 | 6,349 | 230 | 68 | 36 |
Revenue (₹ Cr) |
1 | 851 | 136 | 80 | 70 |
Net Profit (₹ Cr) |
-0.77 | 236.31 | -26.43 | 3.51 | 1.77 |
Net Margin (%) |
-82.45 | 27.06 | -18.78 | 4.39 | 2.53 |
RoE (%) |
-- | 57.63 | -319.95 | 14.19 | 4.12 |
Price to Earnings |
-- | 26.85 | -- | 19.27 | 20.46 |
Price-To-Book |
-6.53 | 11.91 | -11.40 | 2.55 | 1.02 |
Income Statement (₹ Cr)
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.93 | 469.07 | 120.33 | 44.92 | 69.93 |
|
Total Income
|
0.93 | 475.48 | 122.53 | 45.00 | 70.38 |
|
Total Expenditure
|
1.43 | 343.74 | 125.33 | 39.78 | 66.93 |
|
EBITDA
|
-0.50 | 125.33 | -5.00 | 5.15 | 3.00 |
|
Depreciation
|
0.00 | 8.71 | 4.98 | 1.02 | 0.68 |
|
EBIT
|
-0.50 | 116.62 | -9.97 | 4.13 | 2.32 |
|
Interest
|
0.00 | 0.97 | 4.46 | 0.62 | 0.11 |
|
Other Income
|
0.00 | 6.41 | 2.19 | 0.08 | 0.44 |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-0.50 | 122.07 | -12.24 | 3.58 | 2.66 |
|
Provision for Tax
|
0.28 | 31.34 | 1.72 | 0.68 | 0.89 |
|
Profit after Tax
|
-0.78 | 90.73 | -13.96 | 2.90 | 1.77 |
Liabilities (₹ Cr)
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
0.13 | 273.02 | 9.49 | 22.36 | 43.67 |
|
Minority Interest
|
-- | -- | 3.40 | -- | -- |
|
Non-Current Liabilities
|
2.74 | 3.02 | 23.12 | 0.57 | 1.77 |
|
Current Liabilities
|
1.59 | 52.27 | 87.98 | 13.13 | 10.42 |
|
Total Liabilities
|
4.46 | 328.31 | 128.76 | 36.06 | 55.87 |
Assets (₹ Cr)
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.00 | 176.14 | 83.22 | 9.66 | 30.55 |
|
Current Assets
|
4.46 | 152.16 | 40.67 | 26.40 | 25.32 |
|
Total Assets
|
4.46 | 328.31 | 128.76 | 36.06 | 55.87 |
|
Total Debt*
|
2.74 | 10.73 | 65.97 | 7.41 | 0.00 |
|
Net Current Assets
|
2.87 | 99.89 | -47.31 | 13.27 | 14.90 |
|
Contingent Liabilities
|
-- | 8.24 | -- | -- | 3.69 |
Cashflow (₹ Cr)
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.46 | 68.63 | 4.83 | 0.07 | 6.12 |
|
Cash Flow from Investing Activities
|
-0.86 | -70.37 | -14.77 | -5.33 | -0.57 |
|
Cash from Financing Activities
|
2.32 | -0.69 | -9.48 | 5.40 | -0.94 |
|
Net Cash Inflow / Outflow
|
0.00 | -2.43 | -19.42 | 0.13 | 4.60 |
Ratios
Profitability Ratios
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-23.54 | 51.64 | -8.94 | 16.68 | 8.06 |
|
ROE (%)
|
0.00 | 39.04 | -86.43 | 13.89 | 5.14 |
|
ROA (%)
|
-16.99 | 33.06 | -10.55 | 9.53 | 3.17 |
|
EBIT Margin (%)
|
-53.18 | 28.09 | -2.33 | 11.63 | 4.93 |
|
Net Margin (%)
|
-83.58 | 19.08 | -11.39 | 6.45 | 2.51 |
|
Cash Profit Margin (%)
|
-83.69 | 21.20 | -7.15 | 7.83 | 3.49 |
Growth Ratios
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-61.52 | 44.59 | 11.57 | 64.57 | 4.08 |
|
EBIT Growth (%)
|
-1,851.77 | 32.47 | -138.57 | 16.58 | 17.58 |
|
Net Profit Growth (%)
|
-574.74 | 31.10 | -1,517.68 | 67.23 | 14.03 |
|
EPS Growth (%)
|
-574.73 | 31.10 | -840.72 | 67.24 | 14.03 |
|
Book Value Growth (%)
|
-513.60 | 41.79 | -88.76 | 14.93 | 5.37 |
Valuation Ratios
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 11.96 | 0.00 | 46.14 | 16.69 |
|
Price / Book Value
|
-4.36 | 19.91 | 129.43 | 5.99 | 0.84 |
|
Dividend Yield (%)
|
0.00 | 0.25 | 0.00 | 0.00 | 3.28 |
|
EV/EBITDA
|
-13.73 | 41.07 | -173.00 | 25.69 | 6.57 |
|
Market Cap (₹ Cr)
|
4.06 | 5,426.22 | 422.59 | 133.98 | 29.48 |
Solvency Ratios
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-2.95 | 0.04 | 20.21 | 0.33 | 0.00 |
|
Short term debt to equity ratio
|
-- | 0.04 | 4.86 | -- | -- |
|
Current Ratio
|
2.81 | 2.91 | 0.46 | 2.01 | 2.43 |
|
Quick Ratio
|
2.49 | 2.69 | 0.32 | 1.55 | 1.42 |
|
Interest Coverage
|
-133.68 | 127.43 | -1.75 | 6.73 | 24.71 |
Operating Efficiency Ratios
| Hemo Organic | Jeena Sikho | Kerala Ayurveda | Source Natur Foods | Sandu Pharma | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
257.12 | 20.81 | 16.04 | 27.24 | 7.74 |
|
Asset Turnover
|
0.20 | 1.71 | 0.95 | 1.64 | 1.25 |
|
Receivable days
|
963.79 | 54.01 | 51.00 | 71.97 | 26.53 |
|
Inventory Days
|
378.08 | 7.29 | 41.35 | 37.82 | 64.25 |
|
Payable days
|
1,020.02 | 81.46 | 128.93 | 33.06 | 51.77 |
|
Cash Conversion Cycle
|
321.86 | -20.16 | -36.58 | 76.73 | 39.02 |